(MedPage Today) — Risk for a rare, potentially blinding eye condition was low, but it was significantly higher in diabetes patients who started semaglutide (Ozempic) versus SGLT2 inhibitors, an observational study of U.S. veterans showed.
Among…
Source link : https://www.medpagetoday.com/ophthalmology/generalophthalmology/119864
Author :
Publish date : 2026-02-12 21:17:00
Copyright for syndicated content belongs to the linked Source.
